Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 4
2006 3
2007 1
2008 2
2015 1
2016 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent.
Tonelli R, Sartini R, Fronza R, Freccero F, Franzoni M, Dongiovanni D, Ballarini M, Ferrari S, D'Apolito M, Di Cola G, Capranico G, Khobta A, Campanini R, Paolucci P, Minucci S, Pession A. Tonelli R, et al. Among authors: dongiovanni d. Leukemia. 2006 Jul;20(7):1307-10. doi: 10.1038/sj.leu.2404221. Epub 2006 Apr 13. Leukemia. 2006. PMID: 16617320 No abstract available.
Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
Dongiovanni D, Daniele L, Barone C, Dongiovanni V, Fissore C, Sapino A, Macrì L, Bussolati G, Buffoni L, Gaspari F, Grillo R, Birocco N, Addeo A, Ciuffreda L, Schena M. Dongiovanni D, et al. Lung Cancer. 2008 Jul;61(1):73-81. doi: 10.1016/j.lungcan.2007.12.007. Epub 2008 Feb 19. Lung Cancer. 2008. PMID: 18243402 Clinical Trial.
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.
Barni S, Maiello E, Di Maio M, Ardizzoni A, Cappuzzo F, Maranzano E, Novello S, Bennati C, Ori A, Rizzoli S, Crinò L; RIGHT-3 study group. Barni S, et al. Lung Cancer. 2015 Nov;90(2):234-42. doi: 10.1016/j.lungcan.2015.08.005. Epub 2015 Aug 19. Lung Cancer. 2015. PMID: 26314614 Free article.
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.
Dongiovanni V, Buffoni L, Berruti A, Dongiovanni D, Grillo R, Barone C, Addeo A, Fissore C, Bertetto O. Dongiovanni V, et al. Among authors: dongiovanni d. Cancer Chemother Pharmacol. 2006 Aug;58(2):203-9. doi: 10.1007/s00280-005-0157-6. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331497 Clinical Trial.
Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.
Daniele L, Macrì L, Schena M, Dongiovanni D, Bonello L, Armando E, Ciuffreda L, Bertetto O, Bussolati G, Sapino A. Daniele L, et al. Among authors: dongiovanni d. Mol Cancer Ther. 2007 Apr;6(4):1223-9. doi: 10.1158/1535-7163.MCT-06-0719. Epub 2007 Apr 3. Mol Cancer Ther. 2007. PMID: 17406029
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M. Barone C, et al. Among authors: dongiovanni d. Anticancer Res. 2008 Mar-Apr;28(2B):1285-91. Anticancer Res. 2008. PMID: 18505067 Free article. Clinical Trial.
14 results